A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 2,008,198 shares of HRTX stock, worth $2.45 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,008,198
Previous 1,993,800 0.72%
Holding current value
$2.45 Million
Previous $6.98 Million 42.73%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.73 - $3.67 $24,908 - $52,840
14,398 Added 0.72%
2,008,198 $4 Million
Q2 2024

Aug 09, 2024

SELL
$2.32 - $3.86 $957,431 - $1.59 Million
-412,686 Reduced 17.15%
1,993,800 $6.98 Million
Q1 2024

May 13, 2024

BUY
$1.71 - $3.06 $894,648 - $1.6 Million
523,186 Added 27.78%
2,406,486 $6.67 Million
Q4 2023

Feb 13, 2024

BUY
$0.54 - $1.82 $859,680 - $2.9 Million
1,592,000 Added 546.52%
1,883,300 $3.2 Million
Q3 2023

Nov 14, 2023

SELL
$0.97 - $1.8 $744,766 - $1.38 Million
-767,800 Reduced 72.5%
291,300 $300,000
Q2 2023

Aug 11, 2023

SELL
$1.11 - $2.88 $90,726 - $235,399
-81,736 Reduced 7.16%
1,059,100 $1.23 Million
Q1 2023

May 12, 2023

BUY
$1.51 - $3.25 $1.23 Million - $2.65 Million
814,336 Added 249.41%
1,140,836 $1.72 Million
Q4 2022

Feb 13, 2023

BUY
$2.25 - $4.67 $734,625 - $1.52 Million
326,500 New
326,500 $816,000
Q2 2021

Aug 13, 2021

SELL
$13.27 - $18.48 $2.16 Million - $3 Million
-162,600 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$14.49 - $20.72 $2.36 Million - $3.37 Million
162,600 New
162,600 $2.64 Million
Q4 2020

Feb 10, 2021

SELL
$14.61 - $22.14 $1.97 Million - $2.98 Million
-134,800 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$13.67 - $17.77 $1.44 Million - $1.87 Million
-105,000 Reduced 43.79%
134,800 $2 Million
Q2 2020

Aug 13, 2020

SELL
$10.89 - $21.47 $8.84 Million - $17.4 Million
-812,092 Reduced 77.2%
239,800 $3.53 Million
Q1 2020

May 14, 2020

BUY
$10.23 - $24.56 $8.91 Million - $21.4 Million
870,892 Added 481.16%
1,051,892 $12.3 Million
Q4 2019

Feb 13, 2020

BUY
$17.42 - $26.61 $3.15 Million - $4.82 Million
181,000 New
181,000 $4.25 Million
Q3 2019

Nov 13, 2019

SELL
$16.36 - $21.39 $1.59 Million - $2.08 Million
-97,400 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$16.93 - $26.22 $1.65 Million - $2.55 Million
97,400 New
97,400 $1.81 Million

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $145M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.